Citi lowered the firm’s price target on Xometry to $25 from $55 and keeps a Buy rating on the shares. The company’s Q4 results were impacted by a combination of macro and changing buyer and supplier behavior that resulted in decelerating order growth throughout into January along with pricing pressures, the analyst tells investors in a research note. However, the firm believes Xometry’s results should improve throughout 2023 as pricing grows, penetration of its largest accounts rises, and the company achieves positive EBITDA in Q4.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on XMTR:
- Xometry Launches In Turkey With The Acquisition Of Tridi, Turkey’s Leading On-Demand Manufacturing Marketplace
- Xometry price target lowered to $27 from $48 at Craig-Hallum
- Xometry price target lowered to $15 from $28 at Lake Street
- Xometry downgraded to Neutral from Overweight at JPMorgan
- Xometry downgraded to Sector Perform from Outperform at RBC Capital
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue